Rapport Therapeutics, Inc. (CIK: 0002012593) EDGAR, Information, Filings... CompaniesBIO.Com

Rapport Therapeutics, Inc.

Mailing address
1325 BOYLSTON STREET, SUITE 401, BOSTON, Delaware, 02215
Phone
857-321-8020
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

Rapport Therapeutics, Inc. (CIK: 0002012593) is an American company incorporated in the state of Massachusetts. Head office is located at 1325 BOYLSTON STREET, SUITE 401, BOSTON, Massachusetts, 02215. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Rapport Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Rapport Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-093334 (34 Act) Size: KB	Aug-08-2024	001-42121 241186089
8-K	Document	Current report filing Acc-no: 0000950170-24-093321 (34 Act) Size: KB	Aug-08-2024	001-42121 241186042
SEC STAFF LETTER	Document	Acc-no: 9999999997-24-003356 ( Act) Size: KB	Jul-26-2024
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000315066-24-001831 (34 Act) Size: KB	Jul-10-2024	005-94532 241108969
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-077868 ( Act) Size: 0 KB	Jul-03-2024
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000769993-24-000280 (34 Act) Size: KB	Jun-24-2024	005-94532 241066004
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000769993-24-000277 (34 Act) Size: KB	Jun-21-2024	005-94532 241061157
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000929638-24-002235 (34 Act) Size: KB	Jun-20-2024	005-94532 241056124
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-24-071732 (34 Act) Size: KB	Jun-14-2024	005-94532 241044565
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-071543 ( Act) Size: 0 KB	Jun-10-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-071541 ( Act) Size: 0 KB	Jun-10-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-071540 ( Act) Size: 0 KB	Jun-10-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-071539 ( Act) Size: 0 KB	Jun-10-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-071538 ( Act) Size: 0 KB	Jun-10-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-071537 ( Act) Size: 0 KB	Jun-10-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-071533 ( Act) Size: 0 KB	Jun-10-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-071532 ( Act) Size: 0 KB	Jun-10-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-071527 ( Act) Size: 0 KB	Jun-10-2024
8-K	Document	Current report filing Acc-no: 0001193125-24-158327 (34 Act) Size: KB	Jun-10-2024	001-42121 241032748
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001193125-24-157474 (33 Act) Size: KB	Jun-07-2024	333-280058 241030353

Recent 20 filings. View all Rapport Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Rapport Therapeutics, Inc. overview
Rapport Therapeutics, Inc. job
Rapport Therapeutics, Inc. stock
Rapport Therapeutics, Inc. ownership
Rapport Therapeutics, Inc. CEO
Rapport Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.